Social anxiety disorder in the West and in the East.
BACKGROUND
Although social anxiety disorder (SAD) is one of the most prevalent psychiatric disorders in epidemiological surveys, concepts of social anxiety have varied from time to time and place to place. In recent years, however, similar assessments and treatments have been utilized across the world.


METHODS
In this paper, current concepts of SAD in the West and the partially related condition known as taijin kyofusho (TKS) in the East are summarized, and trials of selective serotonin reuptake inhibitors (SSRIs) that have been undertaken in both the United States/Europe and in Japan for social anxiety symptoms are reviewed.


RESULTS
Despite differences in the conceptualization of SAD and TKS, social anxiety is a prevalent symptom in many parts of the world. Fluvoxamine is more effective than placebo in randomized controlled trials of SAD in the West and the East.


CONCLUSIONS
Patients suffering from SAD in different parts of the world share many features in common, and certain SSRIs are an effective treatment for this condition globally.
Department of Psychiatry, University of Cape Town, Groote Schuur Hospital (J-2), Anzio Rd., Observatory 7925, Cape Town, South Africa. dan.stein@uct.ac.za
Dan J
DJ
Stein
D000328:Adult; D001208:Asia / Q000453:epidemiology; D002648:Child; D039721:Diagnostic and Statistical Manual of Mental Disorders; D004358:Drug Therapy; D005006:Ethnicity / Q000706:statistics & numerical data*; D005060:Europe / Q000453:epidemiology; D006801:Humans; D009656:North America / Q000453:epidemiology; D010554:Personality Disorders / Q000453:epidemiology; D010641:Phenotype; D010698:Phobic Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000208:ethnology; D015995:Prevalence